众生药业：公司与齐鲁制药签署RAY1225注射液项目许可协议

Group 1 - The core viewpoint of the article is that Zhongsheng Pharmaceutical has signed a licensing agreement for the RAY1225 injection project with Qilu Pharmaceutical, which is expected to positively impact the company's cash flow and future operations [1] - The company has received the initial payment from Qilu Pharmaceutical, which will effectively supplement its cash flow [1] - This agreement is anticipated to optimize the company's cash flow structure and contribute to its future business development [1]